Dotmatics

Want to learn about what's new in Dotmatics ELN & Data Discovery 7.3?

Watch our on demand webinar hosted by Gianpaolo Bravi and Troy Humphreys here: https://www.dotmatics.com/webinars/whats-new-in-eln-and-data-discovery-7-3 to learn about the latest updates!

Webinar | What’s New in ELN & Data Discovery 7.3 Discover the latest features in Dotmatics ELN & Data Discovery 7.3. Watch the on-demand webinar to see how new enhancements streamline workflows, improve data integration, and accelerate scientific research.

We are excited to announce we will be exhibiting at SLAS 2025 in San Diego! Visit our booth 2313 at the San Diego Convention Center to meet with our team of subject matter experts and learn more about Luma!

,
For more information, visit our page:

SLAS 2025 Join us at SLAS 2025, meet with our team of subject matter experts and discover our latest solutions.

🖥️ Watch our on-demand webinar to discover how Geneious Luma provides unparalleled precision and efficiency in the discovery of next-generation multispecific antibodies (msAbs), presented by Christian Olsen!

This presentation delves into the myriad challenges inherent in researching and developing therapeutic msAbs, and showcases how Geneious Luma's computational design platform adeptly addresses these challenges, paving the way for more successful biologics drug treatments. 💊

Watch the webinar here:

Revolutionizing therapeutic antibody engineering with Geneious Luma Watch the on-demand webinar to learn how Geneious Luma is paving the way for more successful biologics drug treatments.

Dotmatics has been featured in Fast Company's recent article: AI’s Quiet Revolution is Accelerating Drug Discovery, Education and More. Discover how AI's quiet revolution is transforming industries like drug discovery and education, offering faster and more efficient solutions! 💊 📚

Read the full article here:

Fast Company: AI’s Quiet Revolution is Accelerating Drug Discovery, Education and More AI is quietly revolutionizing various fields, from accelerating drug discovery to transforming education. Learn how this transformative technology is shaping the future.

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the acquisition of M-Star, a leading computational fluid dynamics (CFD) software company headquartered outside of Baltimore, Maryland. The deal marks the 13th acquisition by Dotmatics expanding its comprehensive, multimodal platform for life sciences research & development and extending its product capabilities in chemicals and materials sciences. The addition of M-Star provides additional opportunities for innovation in the bioprocessing market including the manufacturing of cell and gene therapies in life sciences R&D.

See the press release for more:

Dotmatics Acquires SoftGenetics Expanding Into Clinical and Forensic Genetic Analysis Learn about Dotmatics' expanding presence in bioprocessing and chemicals and materials with the latest M-Star acquisition.

CFO interviewed Rebeca Sanchez Sarmiento, Chief Financial Officer at Dotmatics, on her daily routines, her views on leadership, and her some of her best professional advice. Check out this article to gain insight into what makes her an impactful leader.

https://bit.ly/40IZj26

The 6 a.m. CFO: How Dotmatics’ CFO Rebeca Sanchez Sarmiento Starts Her Day “As a modern-day CFO working in software, there is no such thing as a traditional scope of work.”  

Thinking about AI for your lab? Don't miss our webinar next week as Dan Ormsby discusses the steps to get there. Register now:

Welcome! You are invited to join a webinar: AI-Driven Pharma R&D: Creating an AI-Ready Foundation for your Lab. After registering, you will receive a confirmation email about joining the webinar. This webinar will unveil the transformative impacts of technology and laboratory instrumentation advances in pharmaceutical research, focusing on the challenges and opportunities presented by big data, particularly in the context of drug discovery and development. Our speaker, Dan Ormbsy, Director S...

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the launch of Dotmatics Luma™, a revolutionary new scientific data platform that helps scientists and administrators in life sciences unify and analyze large volumes of data for better decision-making. Luma™ provides customers an out of the box, low-code SaaS platform that flexibly aggregates all relevant data into intelligent data structures enabling clean, reliable data analysis and paving the way for meta-analysis and AI & ML-based algorithms. Learn more about Luma here:

New Dotmatics Luma Scientific Data Platform Dotmatics Luma is the first out-of-the-box, low-code SaaS platform designed together by scientists and technologists to shorten drug discovery funnel, reduce costs of drug therapy R&D.